Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Harvey J. Berger,M.D.Chairman & CEO1,320,6540.71%2015-03-19
Dr. Timothy P. Clackson,PhDPresident, R&D, CSO440,3140.24%2015-03-19
Jay R. LamarcheDirector439,7050.23%2015-01-31
Edward M. FitzgeraldExecutive VP, CFO305,2090.16%2015-03-19
David L. BersteinSVP, Chief IP Counsel226,4490.12%2015-03-19
Dr. John D. Iuliucci,PhDSenior VP, Development132,742less than 0.1%2009-10-01
Sandford D. SmithN/A131,205less than 0.1%2007-06-20
Dr. Athanase Lavidas,PhDDirector119,131less than 0.1%2015-01-31
Dr. Daniel M. Bollag,PhDSr. VP, Reg. Affairs & Quality117,797less than 0.1%2015-03-19
Mr. Frank HaluskaSVP, Clinical R&D, CMO114,124less than 0.1%2015-03-19

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Details
BERSTEIN DAVID LSVP, Chief IP Counsel2015-03-23Sell4,375159,907$8.7238.2-7.22Link
BERSTEIN DAVID LSVP, Chief IP Counsel2015-03-23Sell4,375226,449$8.7238.2-7.22Link
CLACKSON TIMOTHY PPresident, R&D, CSO2015-03-23Sell32,741440,314$8.88290.7-8.9Link
Haluska FrankSVP, Clinical R&D, CMO2015-03-23Sell6,875114,124$8.7159.9-7.12Link
Duvall Martin JEVP, CCO2015-03-23Sell4,83454,950$8.842.5-8.07Link
FITZGERALD EDWARD MExecutive VP, CFO
(Click for the stocks that their CFOs have bought)
2015-03-23Sell9,584305,209$8.7283.6-7.22Link
Bollag Daniel MSr. VP, Reg. Affairs & Quality2015-03-23Sell7,000117,797$8.7261-7.22Link
Cantor Maria ESVP, Corporate Affairs and HR2015-03-23Sell16,954104,881$8.86150.2-8.69Link
Bollag Daniel MSr. VP, Reg. Affairs & Quality2015-03-16Sell34,425110,797$8.62296.7-6.15Link
CLACKSON TIMOTHY PPresident, R&D, CSO2015-02-20Sell49,035428,232$8392.31.13Link
BERGER HARVEY J M DChairman & CEO
(Click for the stocks that their CEOs have bought)
2015-02-12Buy25,0001,864,286$6.83170.818.45Link
Cantor Maria ESVP, Corporate Affairs and HR2015-02-02Sell16,134100,129$6.33102.127.8Link
Bollag Daniel MSr. VP, Reg. Affairs & Quality2015-02-02Sell14,667137,722$6.3392.827.8Link
CLACKSON TIMOTHY PPresident, R&D, CSO2015-02-02Sell14,667428,232$6.3392.827.8Link
Duvall Martin JEVP, CCO2015-02-02Sell14,66750,117$6.3392.827.8Link
FITZGERALD EDWARD MExecutive VP, CFO2015-02-02Sell14,667295,627$6.3392.827.8Link
BERSTEIN DAVID LSVP, Chief IP Counsel2015-02-02Sell14,667222,074$6.3392.827.8Link
Haluska FrankSVP, Clinical R&D, CMO2015-02-02Sell16,134108,499$6.33102.127.8Link
BERGER HARVEY J M DChairman & CEO2015-01-23Buy25,0001,839,286$6.17154.331.12Link
Schlesinger Sarah J.Director2015-01-14Buy2,60015,600$6.6117.222.39Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK